Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMA
2801
DELISTED
Sigmatron International
SGMA
| $410K | ﹤0.01% |
130,887
+3,600
| +3% | +$18.3K |
|
2802
United Fire Group
UFCS
$1.4B
| $410K | ﹤0.01% |
+20,783
| New | +$435K |
|
|
NSTG
2803
DELISTED
NanoString Technologies, Inc.
NSTG
| $410K | ﹤0.01% |
238,600
+37,739
| +19% | +$115K |
|
|
RWT
2804
Redwood Trust
RWT
$570M
| $409K | ﹤0.01% |
+57,400
| New | +$423K |
|
|
RBOT
2805
DELISTED
Vicarious Surgical
RBOT
| $408K | ﹤0.01% |
23,027
+14,450
| +168% | +$526K |
|
|
XYF
2806
X Financial
XYF
$203M
| $408K | ﹤0.01% |
99,675
-11,016
| -10% | -$47.9K |
|
|
FWDI
2807
Forward Industries Inc
FWDI
$311M
| $407K | ﹤0.01% |
53,474
-1,895
| -3% | -$16.1K |
|
2808
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24B
| $407K | ﹤0.01% |
1,900
-1,300
| -41% | -$295K |
|
2809
Global X Cloud Computing ETF
CLOU
$252M
| $405K | ﹤0.01% |
+21,500
| New | +$429K |
|
|
EWCZ
2810
DELISTED
European Wax Center
EWCZ
| $405K | ﹤0.01% |
25,000
-46,400
| -65% | -$836K |
|
2811
Thomson Reuters
TRI
$43.3B
| $403K | ﹤0.01% |
+3,244
| New | +$428K |
|
2812
Solitario Resources
XPL
$68.7M
| $403K | ﹤0.01% |
739,071
-5,100
| -0.7% | -$2.94K |
|
|
IRS
2813
IRSA Inversiones y Representaciones
IRS
$1.25B
| $402K | ﹤0.01% |
+65,582
| New | +$492K |
|
2814
Carter's
CRI
$1.49B
| $401K | ﹤0.01% |
5,800
-185,340
| -97% | -$13.2M |
|
2815
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.66B
| $399K | ﹤0.01% |
5,883
-56,017
| -90% | -$3.91M |
|
2816
Invesco Solar ETF
TAN
$1.45B
| $399K | ﹤0.01% |
+7,700
| New | +$474K |
|
|
AL
2817
DELISTED
Air Lease Corp
AL
| $398K | ﹤0.01% |
+10,100
| New | +$415K |
|
|
ACHL
2818
DELISTED
Achilles Therapeutics
ACHL
| $398K | ﹤0.01% |
437,528
-12,205
| -3% | -$11.6K |
|
2819
Absci
ABSI
$1.4B
| $397K | ﹤0.01% |
300,800
-122,575
| -29% | -$215K |
|
2820
FVCBankcorp
FVCB
$334M
| $396K | ﹤0.01% |
30,875
-1,300
| -4% | -$15.6K |
|
2821
Fidelity D&D Bancorp
FDBC
$312M
| $395K | ﹤0.01% |
8,700
+400
| +5% | +$18.9K |
|
2822
CorMedix
CRMD
$585M
| $394K | ﹤0.01% |
+106,600
| New | +$424K |
|
2823
Ocular Therapeutix
OCUL
$1.91B
| $393K | ﹤0.01% |
125,200
+100,307
| +403% | +$410K |
|
2824
Savara
SVRA
$1.18B
| $393K | ﹤0.01% |
103,900
-138,400
| -57% | -$493K |
|
|
SCTL
2825
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $392K | ﹤0.01% |
836,017
-31,200
| -4% | -$22.3K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 713 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.